IRADIMED CORP (IRMD) Stock Price, Forecast & Analysis
USA - NASDAQ:IRMD - US46266A1097 - Common Stock
IRMD Key Statistics, Chart & Performance
The current stock price of IRMD is 84.64 USD. In the past month the price increased by 15.57%. In the past year, price increased by 62.8%.
IRMD Latest News, Press Relases and Analysis
IRMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.45 | 221.04B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.45 | 205.11B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.75 | 151.88B | ||
| SYK | STRYKER CORP | 27.62 | 139.05B | ||
| IDXX | IDEXX LABORATORIES INC | 56.5 | 57.00B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 54.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.14 | 50.00B | ||
| RMD | RESMED INC | 25.5 | 36.84B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.99 | 33.52B | ||
| PODD | INSULET CORP | 71.4 | 22.97B | ||
| DXCM | DEXCOM INC | 31.25 | 22.80B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About IRMD
Company Profile
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 160 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Company Info
IRADIMED CORP
12705 Ingenuity Drive
Orlando FLORIDA 32708 US
CEO: Roger Susi
Employees: 160
Phone: 14076778022
IRADIMED CORP / IRMD FAQ
Can you describe the business of IRADIMED CORP?
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 160 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
What is the stock price of IRADIMED CORP today?
The current stock price of IRMD is 84.64 USD. The price decreased by -1.66% in the last trading session.
What is the dividend status of IRADIMED CORP?
IRADIMED CORP (IRMD) has a dividend yield of 0.79%. The yearly dividend amount is currently 1.08.
How is the ChartMill rating for IRADIMED CORP?
IRMD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the employee count for IRMD stock?
IRADIMED CORP (IRMD) currently has 160 employees.
What is the next earnings date for IRMD stock?
IRADIMED CORP (IRMD) will report earnings on 2026-02-11, before the market open.
What is the ownership structure of IRADIMED CORP (IRMD)?
You can find the ownership structure of IRADIMED CORP (IRMD) on the Ownership tab.
IRMD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to IRMD. When comparing the yearly performance of all stocks, IRMD is one of the better performing stocks in the market, outperforming 90.58% of all stocks.
IRMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to IRMD. IRMD gets an excellent profitability rating and is at the same time showing great financial health properties.
IRMD Financial Highlights
Over the last trailing twelve months IRMD reported a non-GAAP Earnings per Share(EPS) of 1.82. The EPS increased by 13.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.31% | ||
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| Debt/Equity | 0 |
IRMD Forecast & Estimates
8 analysts have analysed IRMD and the average price target is 76.5 USD. This implies a price decrease of -9.62% is expected in the next year compared to the current price of 84.64.
For the next year, analysts expect an EPS growth of 12.51% and a revenue growth 11.05% for IRMD